SCHEMBL6349587

SCHEMBL6349587

O=C(Nc1ccc(Br)cc1C(=O)O)c1ccc2c(c1)OCO2

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.64
RAB9A P51151 7/20 0.64
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
CASP3 P42574 2/20 0.64
SENP7 Q9BQF6 2/20 0.64
PTGS2 P35354 1/20 0.61
AKR1C2 P52895 2/20 0.60
AKR1C1 Q04828 2/20 0.60
AKR1C4 P17516 1/20 0.60
AKR1C3 P42330 1/20 0.60
P2RX4 Q99571 2/20 0.57
PKM P14618 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
GPR35 Q9HC97 1/20 0.56
MAPT P10636 3/20 0.56
ALDH1A1 P00352 2/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6350714 0.91 MAPT (0.65) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL17166275 0.82 AKR1C2 (0.73) MEN1KMT2AAKR1C2AKR1C1AKR1C4
SCHEMBL6351992 0.82 NPC1 (0.61) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL6830367 0.79 NPC1 (0.74) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL6359308 0.79 SERPINE1 (0.68) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL2272541 0.79 PTGS2 (0.63) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL6360688 0.78 SERPINE1 (0.64) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL6348852 0.78 AKR1C2 (0.72) RAB9AMEN1KMT2AAKR1C2AKR1C1
SCHEMBL6833148 0.78 NPC1 (0.51) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL2277756 0.77 PTGS2 (0.57) NPC1RAB9AMEN1KMT2ACASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 NPC1 3512/4885RAB9A 3062/4885MEN1 3274/4885
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 NPC1 3778/4885RAB9A 4337/4885MEN1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.